Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 322

1.

Population pharmacokinetics of colistin and the relation to survival in critically ill patients infected with colistin susceptible and carbapenem-resistant bacteria.

Kristoffersson AN, Rognås V, Brill MJE, Benattar YD, Durante-Mangoni E, Daitch V, Skiada A, Lellouche J, Nutman A, Kotsaki A, Andini R, Eliakim-Raz N, Bitterman R, Antoniadou A, Karlsson MO, Theuretzbacher U, Leibovici L, Daikos GL, Mouton JW, Carmeli Y, Paul M, Friberg LE.

Clin Microbiol Infect. 2020 Mar 22. pii: S1198-743X(20)30160-9. doi: 10.1016/j.cmi.2020.03.016. [Epub ahead of print]

PMID:
32213316
2.

FT-IR Spectroscopy is a New Option for Outbreak Investigation: A Retrospective Analysis of an ESBL-producing Klebsiella pneumoniae Outbreak in a Neonatal Intensive Care Unit.

Rakovitsky N, Frenk S, Kon H, Schwartz D, Temkin E, Solter E, Paikin S, Cohen R, Schwaber MJ, Carmeli Y, Lellouche J.

J Clin Microbiol. 2020 Mar 11. pii: JCM.00098-20. doi: 10.1128/JCM.00098-20. [Epub ahead of print]

PMID:
32161093
3.

Performance of Rapid Polymyxin™ NP and Rapid Polymyxin™ Acinetobacter for the detection of polymyxin resistance in carbapenem-resistant Acinetobacter baumannii and Enterobacterales.

Kon H, Abramov S, Amar Ben Dalak M, Elmaliach N, Schwartz D, Carmeli Y, Lellouche J.

J Antimicrob Chemother. 2020 Feb 28. pii: dkaa050. doi: 10.1093/jac/dkaa050. [Epub ahead of print]

PMID:
32108898
4.

National Policy for CRE Clearance and Discontinuation of Contact Precautions for CRE Carriers in Post-Acute Care Hospitals in Israel: Impact on Isolation-Days and New Acquisitions.

Ben-David D, Masarwa S, Fallach N, Temkin E, Solter E, Carmeli Y, Schwaber MJ.

Clin Infect Dis. 2020 Feb 8. pii: ciaa123. doi: 10.1093/cid/ciaa123. [Epub ahead of print]

PMID:
32034414
5.

Colistin Resistance Development Following Colistin-Meropenem Combination Therapy vs. Colistin Monotherapy in Patients with Infections Caused by Carbapenem-Resistant Organisms.

Dickstein Y, Lellouche J, Schwartz D, Nutman A, Rakovitsky N, Dishon Benattar Y, Altunin S, Bernardo M, Iossa D, Durante-Mangoni E, Antoniadou A, Skiada A, Deliolanis I, Daikos GL, Daitch V, Yahav D, Leibovici L, Rognås V, Friberg LE, Mouton JW, Paul M, Carmeli Y; AIDA study group.

Clin Infect Dis. 2019 Nov 23. pii: ciz1146. doi: 10.1093/cid/ciz1146. [Epub ahead of print]

PMID:
31758195
6.

Reply to Wilson et al.

Dickstein Y, Leibovici L, Carmeli Y, Daikos G, Durante-Mangoni E, Friberg LE, Paul M.

Clin Infect Dis. 2019 Nov 17. pii: ciz1100. doi: 10.1093/cid/ciz1100. [Epub ahead of print] No abstract available.

PMID:
31734694
7.

Environmental contamination by carbapenem-resistant Acinetobacter baumannii: The effects of room type and cleaning methods.

Lerner AO, Abu-Hanna J, Carmeli Y, Schechner V.

Infect Control Hosp Epidemiol. 2020 Feb;41(2):166-171. doi: 10.1017/ice.2019.307.

PMID:
31722777
8.

Clostridium difficile-associated disease and Helicobacter pylori seroprevalence: A case-control study.

Muhsen K, Na'amnih W, Adler A, Carmeli Y, Cohen D.

Helicobacter. 2020 Feb;25(1):e12668. doi: 10.1111/hel.12668. Epub 2019 Nov 13.

PMID:
31721371
9.

Personalized Ertapenem Prophylaxis for Carriers of Extended-spectrum β-Lactamase-producing Enterobacteriaceae Undergoing Colorectal Surgery.

Nutman A, Temkin E, Harbarth S, Carevic B, Ris F, Fankhauser-Rodriguez C, Radovanovic I, Dubinsky-Pertzov B, Cohen-Percia S, Kariv Y, Buchs N, Schiffer E, Fallach N, Klausner J, Carmeli Y; Resistance in Gram-negative Organisms: Studying Intervention Strategies (R-GNOSIS) WP4 Study Group.

Clin Infect Dis. 2019 Jun 19. pii: ciz524. doi: 10.1093/cid/ciz524. [Epub ahead of print]

PMID:
31613316
10.

The possibility of transmitting infections with vaginal ultrasound probes: why the guidelines must be met

Schwaber M, Vaturi A, Rubinovitch B, Ben-David D, Solter E, Carmeli Y.

Isr Med Assoc J. 2019 Aug 1;21(8):568-569. No abstract available.

11.

Antimicrobial use trends, Israel, 2012 to 2017.

Dickstein Y, Temkin E, Ben-David D, Carmeli Y, Schwaber MJ.

Euro Surveill. 2019 Aug;24(34). doi: 10.2807/1560-7917.ES.2019.24.34.1900022.

12.

Likelihood of persistent carriage of carbapenem-resistant Acinetobacter baumannii on readmission in previously identified carriers.

Nutman A, Lerner A, Fallach N, Schwartz D, Carmeli Y.

Infect Control Hosp Epidemiol. 2019 Oct;40(10):1188-1190. doi: 10.1017/ice.2019.210. Epub 2019 Aug 5.

PMID:
31379306
13.

External validation of the INCREMENT-CPE mortality score in a carbapenem-resistant Klebsiella pneumoniae bacteraemia cohort: the prognostic significance of colistin resistance.

Machuca I, Gutiérrez-Gutiérrez B, Rivera-Espinar F, Cano A, Gracia-Ahufinger I, Guzman-Puche J, Marfil-Pérez E, Pérez-Nadales E, Castón JJ, Bonomo RA, Carmeli Y, Paterson D, Pascual Á, Martínez-Martínez L, Rodríguez-Baño J, Torre-Cisneros J; REIPI/ESGBIS/INCREMENT Group.

Int J Antimicrob Agents. 2019 Oct;54(4):442-448. doi: 10.1016/j.ijantimicag.2019.07.017. Epub 2019 Aug 1.

PMID:
31377343
14.

The association between implementation of second-tier prevention practices and CLABSI incidence: A national survey.

Ben-David D, Vaturi A, Solter E, Temkin E, Carmeli Y, Schwaber MJ; Israel CLABSI Prevention Working Group.

Infect Control Hosp Epidemiol. 2019 Oct;40(10):1094-1099. doi: 10.1017/ice.2019.190. Epub 2019 Jul 24. Erratum in: Infect Control Hosp Epidemiol. 2019 Nov;40(11):1332.

PMID:
31339089
15.

Trends in antimicrobial resistance in Israel, 2014-2017.

Dickstein Y, Temkin E, Ish Shalom M, Schwartz D, Carmeli Y, Schwaber MJ.

Antimicrob Resist Infect Control. 2019 Jun 4;8:96. doi: 10.1186/s13756-019-0535-1. eCollection 2019.

16.

Estimating the association between antibiotic exposure and colonization with extended-spectrum β-lactamase-producing Gram-negative bacteria using machine learning methods: a multicentre, prospective cohort study.

Tacconelli E, Górska A, De Angelis G, Lammens C, Restuccia G, Schrenzel J, Huson DH, Carević B, Preoţescu L, Carmeli Y, Kazma M, Spanu T, Carrara E, Malhotra-Kumar S, Gladstone BP.

Clin Microbiol Infect. 2020 Jan;26(1):87-94. doi: 10.1016/j.cmi.2019.05.013. Epub 2019 May 23.

PMID:
31128285
17.

Zero or More: Methodological Challenges of Counting and Estimating Deaths Related to Antibiotic-resistant Infections.

Temkin E, Carmeli Y.

Clin Infect Dis. 2019 Nov 13;69(11):2029-2034. doi: 10.1093/cid/ciz414.

PMID:
31102400
18.

Microbiological diagnostics of bloodstream infections in Europe-an ESGBIES survey.

Idelevich EA, Seifert H, Sundqvist M, Scudeller L, Amit S, Balode A, Bilozor A, Drevinek P, Kocak Tufan Z, Koraqi A, Lamy B, Mareković I, Miciuleviciene J, Müller Premru M, Pascual A, Pournaras S, Saegeman V, Schønheyder HC, Schrenzel J, Strateva T, Tilley R, Wiersinga WJ, Zabicka D, Carmeli Y, Becker K; ESCMID Study Group for Bloodstream Infections, Endocarditis and Sepsis (ESGBIES).

Clin Microbiol Infect. 2019 Nov;25(11):1399-1407. doi: 10.1016/j.cmi.2019.03.024. Epub 2019 Apr 10.

PMID:
30980927
19.

Droplet aerosol dissemination of carbapenem-resistant Acinetobacter baumannii surrounding ventilated patients.

Mousa M, Schwartz D, Carmeli Y, Nutman A.

Infect Control Hosp Epidemiol. 2019 Mar;40(3):365-367. doi: 10.1017/ice.2018.335. Epub 2019 Feb 18.

PMID:
30773156
20.

A 5-day course of oral antibiotics followed by faecal transplantation to eradicate carriage of multidrug-resistant Enterobacteriaceae: a randomized clinical trial.

Huttner BD, de Lastours V, Wassenberg M, Maharshak N, Mauris A, Galperine T, Zanichelli V, Kapel N, Bellanger A, Olearo F, Duval X, Armand-Lefevre L, Carmeli Y, Bonten M, Fantin B, Harbarth S; R-Gnosis WP3 study group.

Clin Microbiol Infect. 2019 Jul;25(7):830-838. doi: 10.1016/j.cmi.2018.12.009. Epub 2019 Jan 4.

Supplemental Content

Loading ...
Support Center